- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- October 2024
- 136 Pages
North America
From €3640EUR$4,000USD£3,121GBP
- Report
- November 2018
- 30 Pages
China
From €2002EUR$2,200USD£1,716GBP
- Report
- February 2024
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2025
- 215 Pages
China
From €3640EUR$4,000USD£3,121GBP
- Report
- March 2025
- 109 Pages
China
From €1638EUR$1,800USD£1,404GBP
Benazepril is a cardiovascular drug used to treat high blood pressure and congestive heart failure. It is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the production of a hormone that causes blood vessels to narrow. This helps to relax the blood vessels and reduce blood pressure. Benazepril is also used to reduce the risk of stroke in people with high blood pressure and an enlarged heart.
Benazepril is available in both generic and brand-name forms. It is typically taken once or twice daily, with or without food. Common side effects include dizziness, headache, and fatigue.
The benazepril market is highly competitive, with a number of generic and brand-name drugs available. Companies such as Pfizer, Novartis, and Merck & Co. are among the major players in the market. Other companies include Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more